Telotristat ethyl 250 mg Oral Tablet
RxNorm 1872453
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1872453 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: telotristat ethyl 250 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Telotristat ethyl 250 mg Oral Tablet
(Atom ID: 8730442)
SYPrescribable
Synonym (SY):
Telotristat ethyl 250 mg (as telotristat etiprate 328 mg) Oral Tablet
(Atom ID: 8730338)
PSNPrescribable
Prescribable Name (PSN):
Telotristat ethyl 250 mg Oral Tablet
(Atom ID: 8730448)
Patient Education
Telotristat
Telotristat is used in combination with another medication (a somatostatin analog [SSA] such as lanreotide, octreotide, pasinreotide) to control diarrhea caused by carcinoid tumors (slow-growing tumors that release natural substances that can cause symptoms like diarrhea) in patients with diarrhea not controlled by a somatostatin analog alone. Telotristat is in a class of medications called antidiarrheal agents. It works by blocking the formation of a certain natural substance in the body that is released by the carcinoid tumors and causes diarrhea.
[Learn More]
* Please review the disclaimer below.